COVID-19 treatment coverage with $0 cost share extended to Sept. 30
We'll continue to waive all copays, deductibles and coinsurance for medically necessary treatment of COVID-19 through September 30, 2021.
This means all fully funded commercial*, individual, Medicaid and Medicare members can get the treatment they need for COVID-19 with no out-of-pocket health insurance costs.
Covered treatment may be inpatient or outpatient from an in-network provider. Patients must have a confirmed primary COVID-19 diagnosis and be receiving evidence-based care for treatment to be fully covered.
Get the full details at our COVID-19 Provider information center.
*Employer plans that are self-insured determine benefit coverage for their employees and dependents at their discretion.
Browse news by category
- Authorizations news
- Billing & payment news
- Clinical resources news
- Incentive programs news
- Priority Health news
- Pharmacy news
- Plans & benefits news
- Requirements & responsibilities news
- Training opportunities news
June 13: Medicaid coverage changes in process for Stelara IV and Stelara IV biosimilars
June 11: Updated 2025 HEDIS Provider Reference Guide
June 11: ACNs can still opt into our Exact Sciences colorectal cancer screenings campaign
June 11: Reminder: HMA members have access to Priority Health’s network
June 6: Reminder: You must complete our 15-minute, CMS-required D-SNP Model of Care training by Dec. 31
June 5: Reprocessing 2025 CRNA claims due to payment error
June 5: Mandatory action for prism Security Administrators: Annual pSA renewal process
May 28: Stelara IV coverage changes coming
May 28: Remittance advices for May 2025 care management checks are being delivered late
May 28: Claims with a CS modifier will be denied starting July 28